Use of 2-alpha-cyano-4-alpha, 5-alpha-epoxyandrostan-17-beta-ol-3-o ne derivatives for lowering levels of serum cortisol and for the treatment of clinical conditions associated thereof

Details for Australian Patent Application No. 2002242906 (hide)

Owner Stegram Pharmaceuticals Limited

Inventors Wood, Christopher; Margetts, George

Agent Davies Collison Cave

Pub. Number AU-B-2002242906

PCT Pub. Number WO2002/080930

Priority 0108865.7 09.04.01 GB

Filing date 9 April 2002

Wipo publication date 21 October 2002

Acceptance publication date 2 July 2009

International Classifications

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

A61P 5/08 (2006.01) Drugs for disorders of the endocrine system

A61P 5/42 (2006.01) Drugs for disorders of the endocrine system

A61P 5/46 (2006.01) Drugs for disorders of the endocrine system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 17/14 (2006.01) Drugs for dermatological disorders

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07J 71/00 (2006.01) Steroids in which the cyclopenta[a]hydrophenanthrene skeleton is condensed with a heterocyclic ring

Event Publications

10 April 2003 Application Open to Public Inspection

  Published as AU-B-2002242906

2 July 2009 Application Accepted

  Published as AU-B-2002242906

29 October 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002242907-PROJECTILE WITH FIN DEPLOYMENT MECHANISM

2002242905-CONTROLLING DNA PACKAGING